849: In the Modern ERA, Classifying Localized Prostate Cancer as T1C VS. T2A is of no Prognostic Significance when Predicting the Risk of Biochemical Recurrence | Zendy

AI Assistant Blog Pricing

849: In the Modern ERA, Classifying Localized Prostate Cancer as T1C VS. T2A is of no Prognostic Significance when Predicting the Risk of Biochemical Recurrence

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.